Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

1 month ago 2
ARTICLE AD

Published Mon, Jun 8 20261:02 PM EDTUpdated 7 Min Ago

Read Entire Article
  3. Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

Related

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

LEFT SIDEBAR AD

Hidden in mobile, Best for skyscrapers.